Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

January 31, 2009

Conditions
Healthy
Interventions
DRUG

ABT-143

once, see arm description for more information

DRUG

ABT-335

once, see arm description for more information

DRUG

rosuvastatin

once, see arm description for more detail

Trial Locations (1)

32809

Site Reference ID/Investigator# 14762, Orlando

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY